A detailed history of Intech Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 17,713 shares of VRTX stock, worth $8.9 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
17,713
Previous 19,202 7.75%
Holding current value
$8.9 Million
Previous $9 Million 8.48%
% of portfolio
0.09%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$460.0 - $505.78 $684,940 - $753,106
-1,489 Reduced 7.75%
17,713 $8.24 Million
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $531,471 - $656,922
-1,353 Reduced 6.58%
19,202 $9 Million
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $4.33 Million - $4.74 Million
10,624 Added 106.98%
20,555 $8.59 Million
Q4 2023

Oct 18, 2024

SELL
$343.0 - $410.68 $527,877 - $632,036
-1,539 Reduced 13.42%
9,931 $4.04 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $527,877 - $632,036
-1,539 Reduced 13.42%
9,931 $4.04 Million
Q3 2023

Oct 18, 2024

SELL
$338.18 - $362.46 $5.8 Million - $6.22 Million
-17,156 Reduced 59.93%
11,470 $3.99 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $6.55 Million - $7.02 Million
-19,363 Reduced 62.8%
11,470 $3.99 Million
Q2 2023

Oct 18, 2024

SELL
$314.42 - $351.91 $3.93 Million - $4.4 Million
-12,492 Reduced 30.38%
28,626 $10.1 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $4.19 Million - $4.69 Million
-13,317 Reduced 30.16%
30,833 $10.9 Million
Q1 2023

Oct 18, 2024

BUY
$283.23 - $323.1 $6.21 Million - $7.08 Million
21,916 Added 114.13%
41,118 $13 Million
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $3.58 Million - $4.08 Million
12,631 Added 40.07%
44,150 $13.9 Million
Q4 2022

Oct 18, 2024

BUY
$285.76 - $321.48 $1.67 Million - $1.88 Million
5,843 Added 25.8%
28,487 $8.23 Million
Q4 2022

Feb 09, 2023

BUY
$285.76 - $321.48 $2.54 Million - $2.85 Million
8,875 Added 39.19%
31,519 $9.1 Million
Q3 2022

Oct 18, 2024

BUY
$273.83 - $305.53 $942,522 - $1.05 Million
3,442 Added 17.93%
22,644 $6.56 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $4.32 Million - $4.82 Million
15,771 Added 229.46%
22,644 $6.56 Million
Q2 2022

Aug 10, 2022

BUY
$234.96 - $292.55 $1.61 Million - $2.01 Million
6,873 New
6,873 $1.94 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.